State Street Corp Roivant Sciences Ltd. Transaction History

State Street Corp

  • $2.25 Trillion
  • Q2 2024

A detailed history of State Street Corp transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, State Street Corp holds 18,442,688 shares of ROIV stock, worth $220 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18,442,688
Previous 17,153,134 7.52%
Holding current value
$220 Million
Previous $181 Million 7.82%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$10.36 - $11.74 $13.4 Million - $15.1 Million
1,289,554 Added 7.52%
18,442,688 $195 Million
Q1 2024

May 15, 2024
BUY
$9.87 - $11.8 $33.8 Million - $40.4 Million
3,425,716 Added 24.96%
17,153,134 $181 Million
Q4 2023

Feb 14, 2024
BUY
$8.38 - $11.58 $28.5 Million - $39.4 Million
3,406,626 Added 33.01%
13,727,418 $154 Million
Q3 2023

Nov 14, 2023
BUY
$9.76 - $13.19 $7.68 Million - $10.4 Million
786,896 Added 8.25%
10,320,792 $121 Million
Q2 2023

Aug 14, 2023
BUY
$7.09 - $10.08 $10.6 Million - $15.1 Million
1,500,944 Added 18.68%
9,533,896 $96.1 Million
Q1 2023

May 15, 2023
BUY
$6.92 - $9.98 $31.3 Million - $45.2 Million
4,525,910 Added 129.05%
8,032,952 $59.3 Million
Q4 2022

Feb 14, 2023
BUY
$3.36 - $7.99 $8.74 Million - $20.8 Million
2,601,911 Added 287.46%
3,507,042 $28 Million
Q3 2022

Nov 15, 2022
SELL
$0.51 - $4.84 $97,805 - $928,191
-191,775 Reduced 17.48%
905,131 $2.92 Million
Q2 2022

Aug 15, 2022
BUY
$2.81 - $4.84 $1.82 Million - $3.14 Million
649,000 Added 144.9%
1,096,906 $4.46 Million
Q1 2022

May 16, 2022
BUY
$4.74 - $9.91 $739,942 - $1.55 Million
156,106 Added 53.5%
447,906 $2.21 Million
Q4 2021

Feb 14, 2022
BUY
$5.86 - $13.52 $1.71 Million - $3.95 Million
291,800 New
291,800 $2.94 Million

Others Institutions Holding ROIV

# of Institutions
308
Shares Held
497M
Call Options Held
991K
Put Options Held
1.15M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.39B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email